首页 / 院系成果 / 成果详情页

Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer 期刊论文

编号：

2a33f57a-08a9-4a86-9351-a0ee745831f5
作者：

Liu, Yunhua#^[1,2,3,4]Xu, Hanchen(徐汉辰)#^[1,2,3]Van der Jeught, Kevin^[2,3];Li, Yujing^[2,3];Liu, Sheng^[3];Zhang, Lu^[1,2,3]Fang, Yuanzhang^[2,3];Zhang, Xinna^[3,4];Radovich, Milan(黄诚)^[3,4,5]Schneider, Bryan P.^[6];He, Xiaoming^[7,8,9];Huang, Cheng(黄诚)^[10]Zhang, Chi^[3,11];Wan, Jun^[3,11];Ji, Guang(季光)*^[1]Lu, Xiongbin*^[2,3,4]
语种：

英文
期刊：

JOURNAL OF CLINICAL INVESTIGATION ISSN：0021-9738 2018 年 128 卷 7 期 (2951 - 2965) ; JUL 2
收录：
摘要：

A synthetic lethality-based strategy has been developed to identify therapeutic targets in cancer harboring tumor-suppressor gene mutations, as exemplified by the effectiveness of poly ADP-ribose polymerase (PARP) inhibitors in BRCA1/2-mutated tumors. However, many synthetic lethal interactors are less reliable due to the fact that such genes usually do not perform fundamental or indispensable functions in the cell. Here, we developed an approach to identifying the "essential lethality" arising from these mutated/deleted essential genes, which are largely tolerated in cancer cells due to genetic redundancy. We uncovered the cohesion subunit SA1 as a putative synthetic-essential target in cancers carrying inactivating mutations of its paralog, SA2. In SA2-deficient Ewing sarcoma and bladder cancer, further depletion of SA1 profoundly and specifically suppressed cancer cell proliferation, survival, and tumorigenic potential. Mechanistically, inhibition of SA1 in the SA2-mutated cells led to premature chromatid separation, dramatic extension of mitotic duration, and consequently, lethal failure of cell division. More importantly, depletion of SA1 rendered those SA2-mutated cells more susceptible to DNA damage, especially double-strand breaks (DSBs), due to reduced functionality of DNA repair. Furthermore, inhibition of SA1 sensitized the SA2-deficient cancer cells to PARP inhibitors in vitro and in vivo, providing a potential therapeutic strategy for patients with SA2-deficient tumors.
推荐引用方式
GB/T 7714：

Liu Yunhua,Xu Hanchen,Van der Jeught Kevin, et al. Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer [J].JOURNAL OF CLINICAL INVESTIGATION,2018,128(7):2951-2965.
APA：

Liu Yunhua,Xu Hanchen,Van der Jeught Kevin,Li Yujing,&Lu Xiongbin.(2018).Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer .JOURNAL OF CLINICAL INVESTIGATION,128(7):2951-2965.
MLA：

Liu Yunhua, et al. "Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer" .JOURNAL OF CLINICAL INVESTIGATION 128,7(2018):2951-2965.
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：59  下载次数：0

分享到：

浏览次数：59

下载次数：0

打印次数：0